A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). - Wikidata - wikimedia - TriplyDB

A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).

A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).

http://www.wikidata.org/entity/Q48189448

about

Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis Bridge between neuroimmunity and traumatic brain injury Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: outcomes at 2 years The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions.Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.The hematopoietic factor GM-CSF (granulocyte-macrophage colony-stimulating factor) promotes neuronal differentiation of adult neural stem cells in vitro.Granulocyte-macrophage colony-stimulating factor antibody suppresses microglial activity: implications for anti-inflammatory effects in Alzheimer's disease and multiple sclerosis Granulocyte-macrophage colony-stimulating factor is neuroprotective in experimental traumatic brain injury Multimodal Approaches for Regenerative Stroke Therapies: Combination of Granulocyte Colony-Stimulating Factor with Bone Marrow Mesenchymal Stem Cells is Not Superior to G-CSF Alone.Stem cells for ischemic brain injury: a critical review.Altered T cell responses in children with autism.Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials Granulocyte-macrophage colony stimulating factor exerts protective and immunomodulatory effects in cortical trauma PI3K/Akt signal pathway involved in the cognitive impairment caused by chronic cerebral hypoperfusion in rats.Secretome analysis of human oligodendrocytes derived from neural stem cells Human astrocytes: secretome profiles of cytokines and chemokines.Growth factors in ischemic stroke.A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy.Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice.Motor neuron-immune interactions: the vicious circle of ALS.Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia.Exploring Erythropoietin and G-CSF Combination Therapy in Chronic Stroke Patients.Treatment of Cerebral Palsy with Stem Cells: A Report of 17 Cases.Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue.Optic nerve inflammation and demyelination in a rodent model of nonarteritic anterior ischemic optic neuropathy.Stem cells for enhancing recovery after stroke: a review.Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis Use of growth factors for the treatment of Parkinson's disease.Predicting post-stroke infections and outcome with blood-based immune and stress markers.Cortical gene expression in spinal cord injury and repair: insight into the functional complexity of the neural regeneration program.Neuronal Differentiation Capability of Nasal Polyps of Chronic Rhinosinusitis.VEGF induces neuroglial differentiation in bone marrow-derived stem cells and promotes microglia conversion following mobilization with GM-CSF.Hematopoietic cytokines as therapeutic players in early stages Parkinson's disease.GM-CSF promotes migration of human monocytes across the blood brain barrier.

P2860

Q24201855-1AE82F5E-ABCB-47BC-B5E3-CC689F89B56D Q24655277-54CE2C11-148F-423B-9F24-C4AEF279515A Q26827612-11ACFDBB-2271-44A4-87F3-D51CB47CD02C Q27003260-93C8BFEE-773A-4B9B-B2AA-FD0157B83BAA Q28477416-67914FA9-D7B1-4D0B-8F8C-A7A08CBAA6D4 Q28546716-3CB4EB0B-1A1D-404D-B327-5F0416E5B3F3 Q28710149-A266C8B3-2653-4A9E-9AD8-3632A8CA1283 Q30463376-35B80836-4D96-4E83-871B-9F90D41007F4 Q31109638-074A6246-9DE0-4934-841E-C39EB42308DF Q33303476-2C1755EA-8BC7-469E-9C1C-FB121F63BE85 Q33551339-BB2D81F8-CAD6-46FF-BCDC-3E995B9A7596 Q33576437-0AA35A16-89DD-4DB5-9097-B35B029A3B89 Q33789162-03E789A1-D466-431C-AF25-2810128D0CDB Q33957236-6E99C475-FD53-4968-B708-2F0B185B1DBF Q34577189-56BB5106-4139-431A-B565-3986211D6BD0 Q34972793-F7185E57-1027-40CD-9D84-F4357AB3791D Q34980223-C8B172E2-2F29-427E-99F5-4AFF161DB09E Q35067658-2979A90B-F30C-404A-8872-2630492A37F9 Q35083357-84A47676-EA2E-4C2C-B380-D4674401CAA8 Q35137534-A4A75343-9F45-4C42-9E80-143987A688F2 Q35216143-7F6D0781-8FA4-4FB2-98DF-D2D515E0D7CE Q35554450-D8BAFAC4-D18E-461E-B735-FE6D42DD55A2 Q35613048-2A55381A-C02C-4A43-9E9D-43CE012C92BD Q36373813-210EE0C8-291C-4A7D-BB5A-E767BF82B063 Q36437332-ECECCCAE-F08B-4B3C-A96F-022342D74634 Q36474039-8F71B9D8-AD4A-41AD-B3F2-7B897FB28A86 Q36591794-3E53276B-E775-4CA3-86C8-76F8E5A9B485 Q36846925-594D1B84-34F9-4226-97EC-A676050279AC Q37126560-8B616532-C91C-44A1-B88C-483B878D4802 Q37233361-C65AB0B8-57AC-490F-A066-B62115AE044F Q37372314-4E713CCD-84FA-4B28-B753-8EA6DC08E0B4 Q37453637-8F7B89C0-B14B-4839-AB8E-3226E265EF7C Q37502636-49B7879F-1FCC-46B5-B3E1-567E30ED291E Q37762259-A2558065-D43B-415F-BDAE-599FCBDA0AE7 Q38019812-6B2E7C74-5B93-4A94-BFCF-2F923725B114 Q38589259-9DF84499-F3A7-41B4-8845-238B95DE46AF Q38747812-39D39F28-C8AD-461B-A70A-84B8E9F25719 Q38884418-13D348FF-91F1-4A5F-B925-AD8F3CB7255B Q40719044-3B025098-4CF2-4EA0-9ED7-F089458AD08E Q41254947-5D44E66D-EA83-441B-BD50-DDE7DEC4F946

P2860

A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).

http://www.wikidata.org/entity/Q48189448

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

A neuroprotective function for ...... y stimulating factor (GM-CSF).

@en

A neuroprotective function for ...... hage colony stimulating factor

@nl

type

label

A neuroprotective function for ...... y stimulating factor (GM-CSF).

@en

A neuroprotective function for ...... hage colony stimulating factor

@nl

prefLabel

A neuroprotective function for ...... y stimulating factor (GM-CSF).

@en

A neuroprotective function for ...... hage colony stimulating factor

@nl

P1433

Q48189448-C1F10CD9-3A72-48F3-A214-DC6A700EF7DD

P1476

Q48189448-E30F16B3-7702-4114-A089-F88BAB12F76B

P2093

Q48189448-06C8DD87-C3C0-42BE-AE85-0D528C368A1C

Q48189448-29DE027C-15F3-4085-BF25-1DE40E6B6656

Q48189448-2D087FC7-8F62-4145-AF54-5557FE46E8C3

Q48189448-3DBCEABB-8212-4CB5-8EEF-22BE1E4070E3

Q48189448-73EB96E8-4846-4861-83E9-693FD27C0B4F

Q48189448-7EC8C357-8D73-445C-80F1-D48AB9A05896

Q48189448-9136F7FF-B408-420F-96D2-96D3CEBCC55D

Q48189448-94EC3393-C153-45B8-87A7-472E2349BCBF

Q48189448-C78346D2-464F-4EB9-8E12-49CB62FE41A2

Q48189448-D0FD79A2-0518-4586-A930-FD80DCB0BBD0

P2860

Q48189448-0590F9FE-B743-45C2-B4E9-3B2795B2C52B

Q48189448-0766CBD0-33EC-494E-904F-BE3629E6389A

Q48189448-0A3BA380-91FD-41E1-AC30-698E1D3F8F29

Q48189448-0CD2C93B-ABEB-4BA2-A046-BEB5B4B9B97D

Q48189448-0D6F91C0-E696-45CD-BC4E-B4AD7BC7A8D9

Q48189448-12DAF0CC-0409-4DFB-AB0B-B58F62BCAAE5

Q48189448-196B6432-603E-45D2-86CA-48E8E3A11B6D

Q48189448-2056B6B6-99A3-4B61-9064-4ACC53641614

Q48189448-297B1BD7-2707-4480-A379-03B1E6D79926

Q48189448-2FFD888F-ACF3-4D69-A151-8644E62E0E91

P304

Q48189448-24C1EFDD-A322-4DEC-AA55-1277C1818020

P31

Q48189448-A2D8799A-B822-4547-9D5A-50CB716B9AEA

P356

Q48189448-5BE39631-6AB4-4D27-B17D-27954B845AF8

P433

Q48189448-90C61DF5-197B-4E2C-9A79-806C31086257

P478

Q48189448-D414AB92-F58D-4964-B7A6-80187C582F7F

P50

Q48189448-4A4055E3-B7E4-43F3-B4C8-5450D0C8D09D

Q48189448-A5FF4AC9-A498-4759-8551-1D480826EE07

P577

Q48189448-CB65D69F-2121-4E05-8A78-840AFD5C93C6

P5875

Q48189448-AF4E1148-65E8-4EDA-A330-C5A3D6850FF1

P698

Q48189448-62522964-9DA4-454D-B967-EFE8D6B2D5BB

P921

Q48189448-E84FEED3-154D-487F-9313-602C92C9FB0D

P356

SJ.JCBFM.9600496

P1433

Journal of Cerebral Blood Flow & Metabolism

P1476

A neuroprotective function for ...... y stimulating factor (GM-CSF).

@en

P2093

Alfred Bach

http://www.w3.org/2001/XMLSchema#string

Carola Krüger

http://www.w3.org/2001/XMLSchema#string

Claudia Pitzer

http://www.w3.org/2001/XMLSchema#string

Clemens Sommer

http://www.w3.org/2001/XMLSchema#string

Daniela Weber

http://www.w3.org/2001/XMLSchema#string

Friederike Kirsch

http://www.w3.org/2001/XMLSchema#string

Jaroslaw Aronowski

http://www.w3.org/2001/XMLSchema#string

Nikolaus Gassler

http://www.w3.org/2001/XMLSchema#string

Rico Laage

http://www.w3.org/2001/XMLSchema#string

Tanjew Dittgen

http://www.w3.org/2001/XMLSchema#string

P2860

The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis

Sargramostim for active Crohn's disease

GM-CSF action in the CNS decreases food intake and body weight.

Therapeutic induction of arteriogenesis in hypoperfused rat brain via granulocyte-macrophage colony-stimulating factor.

Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia.

Granulocyte-macrophage colony-stimulating factor-induced arteriogenesis reduces energy failure in hemodynamic stroke

An extended window of opportunity for G-CSF treatment in cerebral ischemia.

Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.

Central nervous system injury-induced immune deficiency syndrome.

Toward a multimodal neuroprotective treatment of stroke.

P304

29-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.JCBFM.9600496

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Armin Schneider

P577

2007-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6372560

http://www.w3.org/2001/XMLSchema#string

P698

17457367

http://www.w3.org/2001/XMLSchema#string

P921